CAI (ASX) An email I sent and no reply :(

Originally posted by nathanblack ↑

Great email and idea. Maybe they are slow getting back to you because they will meet and discuss before replying?

I think you hit nail on the head. The tax losses are by far the most valuable asset. If the restructure goes ahead and we become DDZ then the tax losses aren't useable by us. So selling them would be benefitial.

Our main assets would be:
1. Tax losses - only useable in related business.
2. Thermalife - not profitable over 20years.
3. manufacturing process - cheap but inferior and unstable product.
4. Tripeptofen - Promising but we cant find it and reserach has stopped.
5. Inventory - Production ceased and most batches are nearing expiry.

Obviously the seniority of the convertible notes/debt is the biggest obsticle in any restructure/take over/merger. Especially when the majority of notes are also in dispute and unlikely to compromise beyond a certain point. But if they get full face value its a no brainer. If they get 50% you'd think they'd take that given the likelyhood of getting nothing under current circumstances.

I think you can find a buyer for Thermalife and it can be profitable. It just cant be an asx listed buyer. Its a bouttique product with bouttique volumes and margins. It is best suited to private company with low overheads and contract production every 6months to top up inventory.

Their is no goodwill payment for the PNO brand as it is nothing. And similar for Thermalife. The brand is small and worthless. You get the name for free when you buy the company and the buyer might do away with it anyway and rebrand.

Its obvious why Anthony wants restructure. He stands to lose the least under that scenario. And the creditors are basically working for him as largest creditor. But I'm sure they are open to reasonable offers for the business or parts of.

I really dont know how it got this bad. Obviously losses aren't sustainable and it gets harder and harder to raise capital which is why our cap raisings started to fail. Then we cut all spending and lived of internal funding. But that isn't even a bandaid solution as every quarterly kept highlighting that basically we were on life support and spending nothing on R&D/Production/Marketing. So we were never going to dig out of the hole.

Anthony didn't push us into administation. He just made it come a few months earlier. We were always going there with or without him.

What really needed to happen was a share consoldiation and large write down. They could have done 50 to one. So instead of 0.1c the shares are 5c. Then raise at 2.5c and they'd have buyers. Could even find underwriters on those terms with some nice in the money options to sweeten the deal.

Instead they let it go over a year without a successful CR. Two failed attempts that rang alarm bells and locked the sp to 0.1c with no bids. And the reaction was to close ranks and pump in trivial amount of money from own pocket which he got back as salary.

Hard decisions needed to be made. New management was one option which sadly has had to happen now with Johns passing. But it was too late. The notes needed to be dealt with in a permanent way. Either by converting them and diluting everyone, or as a minimum they needed to be renegotiated to be long term instead of maturing every 12months which equated to every few months since their were several series of notes with different maturity dates.

OBJ had more room to move, but when their CR failed "due to Boston bombing"., they were quick to appoint Baker and Young. And the CR went ahead and succeeded. The rest is history. They aren't perfect. They've been up and down and are probably lower than they should be. But they did the failed CR better than PNO. And their business model of letting others fund research was better and kept costs low and less reliance on CR.

PNO often talked the talked but never walked the walk. Some feel that way about OBJ. The difference is even if you think nothing will come of any of the OBJ partnerships, then it still cost them nothing. With PNO we anounce things like the distribution agreement which WE paid for. Then when it fails we terminate it. WE announce partnerships with universities and others to locate Tripeptofen but we fund it. We announce being close to USA deal but no update and nothing eventuates from it.

Clearly it was just talk to try pump the sp and their was a couple ocasions were volume appeared at 0.1c and even the odd nibble at 0.2c and MLPH had some action too. But artificially pumping the sp was never going to get a cr off the ground. Maybe 5years ago. But not 2015. The market wised up.

We were one deal away from digging out of a hole. But we will never know how near or far that deal was. Their was always smoke and we never saw the fire. Rather than searching for a company making sales/licensing deal they should have focused on research deals. If we cut cost via a research deal and actually found something concrete we'd have a viable and sellable asset.

Its definitely not over for the product or the company. But things will never be the same. We are a nice shell now and have no MD. So ripe for a reverese take over.

Expand

Hi Nathanblack,

yes in my proposal, it doesnt cost OBJ a cent ! in fact they get everything for free and given a couple of mill by the taxman.

Why wouldnt they do it? Would they need shareholder approval? Can they issue the shares under asx rules without approval? its less than 15% of issue..

I see it as a win win.. Pno holders have salvaged something and OBJ get something for nothing.. Im sure some of the big players like P & G may throw a few $$ around to see potential if OBJ had it. And there was that Material agreement ready to be signed...

The entity must still be in the wings...

I wonder if Anthony palermo reads Hotcopper, i didnt know his email details to include him in it. Someone may also want to forward it to the administrators for comment???? to be officially be put on the table????

No.	Vol.	Price($)
7	287120	12.5¢

No.

Vol.

Price($)

287120

12.5¢

Price($)	Vol.	No.
13.0¢	675508	6

Price($)

Vol.

No.

13.0¢

675508

No.	Vol.	Price($)
7	287120	0.125
27	1167974	0.120
16	1836177	0.115
10	790899	0.110
8	969997	0.105

No.

Vol.

Price($)

287120

0.125

1167974

0.120

1836177

0.115

790899

0.110

969997

0.105

Price($)	Vol.	No.
0.130	675508	6
0.135	767829	10
0.140	770863	12
0.145	258000	2
0.150	546121	10

Price($)

Vol.

No.

0.130

675508

0.135

767829

0.140

770863

0.145

258000

0.150

546121

(20min delay)
Last 12.5¢		Change -0.005(3.85%)		Mkt cap ! $95.16M

Open	High	Low	Value	Volume
13.0¢	13.0¢	12.5¢	$120.4K	935.4K


Last 12.5¢		Change -0.005 ( 1.96 %)
Open	High	Low	Volume
12.8¢	13.0¢	12.5¢	290934
Last updated 15.53pm 14/05/2024 ?

Hi Nathanblack, yes in my proposal, it doesnt cost OBJ a cent !...

Featured News

BHP fails to secure second takeover offer to Anglo American

Magnum to raise US$210M to advance Saudi green pig iron plant

D3E joins ASX as it hunts natural gas and helium in South Africa

Breaking barriers in cancer treatment: Race Oncology pioneers a new era with bisantrene

Meet Sun Silver – ASX's newest silver-gold player based in Nevada, USA

Buyers (Bids)

Sellers (Offers)

Featured News

Hi Nathanblack, yes in my proposal, it doesnt cost OBJ a cent !...

Featured News

Top Stories

BHP fails to secure second takeover offer to Anglo American

Magnum to raise US$210M to advance Saudi green pig iron plant

D3E joins ASX as it hunts natural gas and helium in South Africa

Breaking barriers in cancer treatment: Race Oncology pioneers a new era with bisantrene

Meet Sun Silver – ASX's newest silver-gold player based in Nevada, USA

Buyers (Bids)

Sellers (Offers)

Featured News